Compare · CRTO vs SRAX
CRTO vs SRAX
Side-by-side comparison of Criteo S.A. (CRTO) and SRAX Inc. (SRAX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRTO and SRAX operate in Advertising (Consumer Discretionary), so they compete in similar markets.
- CRTO carries a market cap of $887.3M.
- CRTO has hit the wire 12 times in the past 4 weeks while SRAX has been quiet.
- CRTO has more recent analyst coverage (18 ratings vs 0 for SRAX).
- Company
- Criteo S.A.
- SRAX Inc.
- Price
- -
- -
- Market cap
- $887.3M
- -
- 1M return
- +14.72%
- -
- 1Y return
- -9.30%
- -
- Industry
- Advertising
- Advertising
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2013
- News (4w)
- 12
- 0
- Recent ratings
- 18
- 0
Criteo S.A.
Criteo S.A., a technology company, provides marketing and monetization services on the open Internet in North and South America, Europe, the Middle East, and Africa, and the Asia-Pacific. The company's Criteo Shopper Graph, which derives clients' proprietary commerce data, such as transaction activity on their digital properties. Its Criteo AI Engine solutions include lookalike finder, recommendation, and predictive bidding algorithms; bidding engine that executes campaigns based on certain objectives set by its clients; dynamic creative optimization+, which assembles customized creative advertising content by optimizing each individual creative component in the advertisement; software systems and processes, which enable data synchronization, storage, and analysis of distributed computing infrastructure in various geographies; and experimentation platform, an offline/online testing platform to enhance the capabilities and effectiveness of prediction models. The company also provides Criteo Marketing Solutions that allow commerce companies to address various marketing goals by engaging their consumers with personalized ads across the web, mobile, and offline store environments; and Criteo Retail Media solutions, which allows retailers to generate advertising revenues from consumer brands, and/or to drive sales for themselves, by monetizing their data and audiences through personalized ads, either on their own digital property or on the open Internet. In addition, it offers real-time access to advertising inventory through its publisher partners; consulting services to companies in distance sales; and business intelligence and analytics services. It serves companies in digital retail, travel, and classifieds industries. The company was incorporated in 2005 and is headquartered in Paris, France.
SRAX Inc.
SRAX, Inc., a technology company, focused on enhancing communications between public companies and their shareholders and investors in the United States. The company offers Sequire, a Saas platform that allows issuers to track their shareholders' behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. It also organizes and hosts investor conferences within the micro and small- cap space. The company markets and sells its services through its in-house sales and marketing team. The company was formerly known as Social Reality, Inc. and changed its name to SRAX, Inc. in August 2019. SRAX, Inc. was founded in 2009 and is headquartered in Westlake Village, California.
Latest CRTO
- Amendment: SEC Form SCHEDULE 13G/A filed by Criteo S.A.
- Amendment: SEC Form SCHEDULE 13G/A filed by Criteo S.A.
- Criteo Announces Inclusion in MSCI Global Investable Market Indexes
- SEC Form 3 filed by new insider Mao Jianchang
- SEC Form DEFM14A filed by Criteo S.A.
- SEC Form 10-Q filed by Criteo S.A.
- Criteo S.A. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Criteo Expands Performance CTV Capabilities Across Global Markets
- CRITEO REPORTS THIRD QUARTER 2026 RESULTS
- SEC Form 8-K filed by Criteo S.A.
Latest SRAX
- GPOPlus+ to Present at the Sequire Investor Summit on January 20th - 22nd in San Juan, Puerto Rico
- SEC Form 10-Q filed by SRAX Inc.
- SEC Form 10-Q filed by SRAX Inc.
- SEC Form 10-K filed by SRAX Inc.
- June 7, 2024 - FDA Roundup: June 7, 2024
- SEC Form 8-K filed by SRAX Inc.
- SRAX Signs Agreement to Merge with DNA Holdings
- SRAX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SRAX Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- March 22, 2024 - FDA Roundup: March 22, 2024